ASX Announcement

Nasodine COVID-19 trial receives SAHPRA approval

Published: 01/02/22, 09:50am (AEST)2 pages
Firebrick Pharma Limited
FRE:ASXHealthcare

Recent FRE Announcements

Price Sensitive only